Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


V.BTI.H

Is Bioasis attending this BBB conference?

Digital posted a talk title for Danica Stanimirovic at the June 2017...

May 11, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:Financing, etc

It's not clear to me what Torpedoman is getting at with his "...

May 5, 2017

T.RVX

RE:RE:New analyst report with $12.50 target...

Narmac, Van Leeuwenhoeck initiated their Resverlogix coverage in May 2015...

May 3, 2017

T.RVX

RE:RE:Silence

Latest Zacks report indicated that meetings to launch in Taiwan and Russia...

April 26, 2017

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:Bioasis hires Colwell for IR services

Hopefully Colwell can help Bioasis with updating their website. It is in dire...

April 25, 2017

V.BTI.H

RE:Mark This Day!

Nice write up JD. Good to see the JDStox blog revived again. BearDownAZ

April 24, 2017

V.BTI.H

RE:Q2 '17 Presentation on BTI's Website

It does not look like the link for the Q2 2017 presentation links to anything...

April 24, 2017

T.RVX

RE:RE:RE:RE:Exempt Distribution

Item 7f seems to list the info about the purchaser and inidcates that the...

April 21, 2017

T.RVX

RE:RE:Exempt Distribution

Section 7f of that document indicates that there was a single purchaser who...

April 21, 2017

T.RVX

RE:Exempt Distribution

Toniv, I looked at the document that plapper informed us about on SEDAR. I...

April 21, 2017

T.RVX

RE:targeted BETi vs pan BETi

Apabetalone is a targetted, specific BETi and has to date a very good safety...

April 21, 2017

T.RVX

RE:RE:RE:RE:RE:RE:CHINA TRIAL STATUS?

For BETonMACE trial consistency, I am sure that Resverlogix (or the...

April 5, 2017

T.RVX

RE:RE:RE:RE:CHINA TRIAL STATUS?

Toniv wrote "Given that any company can buy and test apabetalone I am...

April 5, 2017

T.RVX

RE:RE:CHINA TRIAL STATUS?

Toniv, As part of the Hepalink deal, and as listed in Resverlogix corporate...

April 5, 2017

T.RVX

RE:Zenith AACR

Toniv, The very next message in that thread on Agoracom contained a quick...

April 4, 2017

T.RVX

RE:Regular Asperin Use

G1945, First of all, you cite an article focused on aspirin and cancer...

April 4, 2017

T.RVX

Vote Resverlogix for the Buzz of BIO Award

Some of you may have received this email from Sarah. Resverlogix is one of...

April 4, 2017

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Note to Recent Sellers...

Interesting artcle about the bee-venom peptide, apamin. Just a...

April 3, 2017

V.BTI.H

RE:RE:RE:Bigger/Gleitz MPSII Research

The Bigger/Gleitz research description states "We developed and cloned 6...

March 31, 2017

V.BTI.H

Bigger/Gleitz MPSII Research

Just to maybe break us out of the boring and start a discussion....... The...

March 31, 2017